Related Experiment Video
Updated: Aug 7, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Kurt Degenhardt1, Robin Mathew, Brian Beaudoin
1Center for Advanced Biotechnology and Medicine, 679 Hoes Lane, Piscataway, New Jersey 08854, USA.
Abstract:
Defective apoptosis renders immortalized epithelial cells highly tumorigenic, but how this is impacted by other common tumor mutations is not known. In apoptosis-defective cells, inhibition of autophagy by AKT activation or by allelic disruption of beclin1 confers sensitivity to metabolic stress by inhibiting an autophagy-dependent survival pathway. While autophagy acts to buffer metabolic stress, the combined impairment of apoptosis and autophagy promotes necrotic cell death in vitro and in vivo. Thus, inhibiting autophagy under conditions of nutrient limitation can restore cell death to apoptosis-refractory tumors, but this necrosis is associated with inflammation and accelerated tumor growth. Thus, autophagy may function in tumor suppression by mitigating metabolic stress and, in concert with apoptosis, by preventing death by necrosis.
Insights
Defective apoptosis makes cells tumorigenic. Inhibiting autophagy in these cells can restore cell death but may cause inflammation and faster tumor growth, suggesting autophagy
Area of Science:
- Cell biology
- Cancer research
- Molecular oncology
Background:
- Defective apoptosis (programmed cell death) is a hallmark of cancer, leading to uncontrolled cell proliferation.
- The interplay between apoptosis, autophagy (cellular self-eating), and common cancer mutations remains incompletely understood.
- Understanding these pathways is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate how common tumor mutations affect apoptosis-defective cells.
- To explore the role of autophagy inhibition in sensitizing these cells to metabolic stress.
- To determine the consequences of combined apoptosis and autophagy defects on cell death and tumor progression.
Main Methods:
- Utilized immortalized epithelial cells with defective apoptosis.
- Manipulated autophagy using AKT activation and beclin1 gene disruption.
- Assessed cell death (apoptosis, necrosis) and tumor growth in vitro and in vivo under metabolic stress conditions.
Main Results:
- Inhibition of autophagy in apoptosis-defective cells, via AKT activation or beclin1 disruption, induced sensitivity to metabolic stress.
- Combined impairment of apoptosis and autophagy led to necrotic cell death.
- Inhibiting autophagy in nutrient-limited, apoptosis-refractory tumors restored cell death but promoted inflammation and accelerated tumor growth.
Conclusions:
- Autophagy inhibition can re-sensitize apoptosis-resistant tumors to cell death, but with detrimental side effects.
- Autophagy may act as a tumor suppressor by managing metabolic stress and preventing necrosis.
- Targeting autophagy in cancer therapy requires careful consideration of its dual role in cell survival and death.
More Related Videos
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cellular Injury V: Apoptosis and Autophagy
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

